Colon cancer screening programs prevent cancer

doi:10.3748/wjg.v30.i42.4566

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 42

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (19)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

Sum=17

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=0

Nov 14, 2024 (publication date) through Oct 31, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Gastroenterol. Nov 14, 2024; 30(42): 4566-4568
Published online Nov 14, 2024. doi: 10.3748/wjg.v30.i42.4566

Colon cancer screening programs prevent cancer

Duncan J Flynn, Joseph D Feuerstein

Duncan J Flynn, Joseph D Feuerstein, Department of Medicine and Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, United States

Co-first authors: Duncan J Flynn and Joseph D Feuerstein.

Author contributions: Flynn DJ and Feuerstein JD contributed to manuscript development.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/

Corresponding author: Joseph D Feuerstein, AGAF, MD, Associate Professor, Attending Doctor, Department of Medicine and Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, 110 Francis St 8E, Boston, MA 02215, United States. jfeuerst@bidmc.harvard.edu

Received: April 28, 2024
Revised: September 9, 2024
Accepted: October 15, 2024
Published online: November 14, 2024
Processing time: 186 Days and 4 Hours

Core Tip

Core Tip: Colon cancer is rising in incidence and prevalence worldwide. Colon cancer screening programs are associated with reduction in cancer diagnoses and in advanced stages of cancer diagnoses. The ideal screening test remains unclear but both fecal immunochemical test (FIT) testing and colonoscopy are both appropriate modalities. Ultimately, if a patient has risk factors or if the FIT test is positive, then colonoscopy should be used to evaluate for colon cancer.